title: Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease.
authors.forename: A M
authors.initials: AM
authors.lastname: Carella
authors.forename: G
authors.initials: G
authors.lastname: Beltrami
authors.forename: M
authors.initials: M
authors.lastname: Carella
authors.forename: M T
authors.initials: MT
authors.lastname: Corsetti
authors.forename: R P
authors.initials: RP
authors.lastname: Scalzulli
authors.forename: M
authors.initials: M
authors.lastname: Greco
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016879:Salvage Therapy; D014184:Transplantation, Homologous / Q000379:methods; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine